Long-acting Reversible Contraceptive (LARC)

Showing 33-40 of 43 results

Research roundup: February 2020 edition

An analysis of the benefits and risks of immediate postpartum IUD insertion, demonstrated improved health outcomes for society as a whole with universal access to contraception, a systematic review of studies of the efficacy and safety of extended IUD use, and more.

Research roundup: January 2020 edition

The CDC’s 2020 recommendations for evidence-based STD care, telehealth abortion consultations to help patients overcome barriers to care, a systematic review of the use of misoprostol prior to IUD insertion, and more.

Research roundup: December 2019 edition

The importance of patient-centered contraceptive counseling, expedited scheduling of interval tubal ligation as a way to improve access to sterilization, a study of barriers to IUD access for adolescent patients, and more.

Research roundup: November 2019 edition

The ACOG Committee Opinion’s support for over-the-counter hormonal contraception, efficacy of intracervical blocks for pain management during levonorgestrel IUD placement, studies on the mechanism of function of ulipristal acetate, and more.

Exciting News—LILETTA now approved for use up to 8 years!

The FDA has extended approval of LILETTA IUDs for up to 6 years of use, research shows they are safe and effective for up to 7 years.

U=U (Undetectable = Untransmittable)

Talking to your patients with HIV about their transmission risk

What makes the Liletta IUD different from Mirena?

Here’s what you and your patients should know about these two (very similar) hormonal IUDs.

Is LARC a silver bullet to end unplanned pregnancy?

Experts weigh in on how many women would use IUDs and implants in the absence of barriers.
  • Previous
  • 2
  • 3
  • 4
  • 5(current)
  • 6
  • Next